Unknown

Dataset Information

A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia.


ABSTRACT:

Objective

Infections and other stressors have been implicated in the development of fibromyalgia. We hypothesized that these stressors could result in recurrent reactivations of latent herpes virus infections, which could lead to the development of fibromyalgia. This study evaluated a famciclovir + celecoxib drug combination (IMC-1), active against suspected herpes virus reactivation and infection, for the treatment of fibromyalgia.

Methods

A total of 143 fibromyalgia patients were enrolled at 12 sites in a 16-week, double-blinded, placebo-controlled proof-of-concept trial. Randomized patients received either IMC-1 or placebo in a 1:1 ratio. Outcome measures included a 24-hour recall pain Numerical Rating Scale, the Revised Fibromyalgia Impact Questionnaire (FIQ-R), the Pati

SUBMITTER: Pridgen WL 

PROVIDER: S-EPMC5328426 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature